LUPIN LTD Company Profile
✉ Email this page to a colleague
What is the competitive landscape for LUPIN LTD, and when can generic versions of LUPIN LTD drugs launch?
LUPIN LTD has one hundred and seventy-four approved drugs.
There is one US patent protecting LUPIN LTD drugs. There are nineteen tentative approvals on LUPIN LTD drugs.
There are two patent family members on LUPIN LTD drugs in two countries and six hundred and nine supplementary protection certificates in seventeen countries.
Summary for LUPIN LTD
International Patents: | 2 |
US Patents: | 1 |
Tradenames: | 148 |
Ingredients: | 132 |
NDAs: | 174 |
Drug Master File Entries: | 194 |
Patent Litigation for LUPIN LTD: | See patent lawsuits for LUPIN LTD |
PTAB Cases with LUPIN LTD as petitioner: | See PTAB cases with LUPIN LTD as petitioner |
Drugs and US Patents for LUPIN LTD
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lupin Ltd | SUPRAX | cefixime | TABLET, CHEWABLE;ORAL | 065380-003 | Oct 25, 2010 | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Lupin Ltd | IRBESARTAN | irbesartan | TABLET;ORAL | 201531-002 | Oct 15, 2012 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lupin Ltd | IMIPRAMINE PAMOATE | imipramine pamoate | CAPSULE;ORAL | 090444-001 | Apr 16, 2010 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lupin Ltd | FAYOSIM | ethinyl estradiol; levonorgestrel | TABLET;ORAL | 205943-001 | Mar 29, 2016 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Lupin Ltd | LEVETIRACETAM | levetiracetam | SOLUTION;ORAL | 090893-001 | Oct 17, 2011 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lupin Ltd | ILOPERIDONE | iloperidone | TABLET;ORAL | 206890-005 | May 5, 2022 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Lupin Ltd | LAMOTRIGINE | lamotrigine | TABLET;ORAL | 078691-003 | Jun 1, 2010 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for LUPIN LTD drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | for Oral Suspension | 500 mg/5 mL | ➤ Subscribe | 2014-07-22 |
➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
➤ Subscribe | Injection | 250 mcg/0.5 mL, 1 mL PFS | ➤ Subscribe | 2012-03-30 |
International Patents for LUPIN LTD Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
World Intellectual Property Organization (WIPO) | 2007119249 | ⤷ Try a Trial |
Germany | 112007000920 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for LUPIN LTD Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1746976 | CA 2017 00030 | Denmark | ⤷ Try a Trial | PRODUCT NAME: IRINOTECAN SUCROSOFATE SALT, SUCH AS IRINOTECAN SUCROSOFATE SALT IN A PEGYLATED LIPOSOME, SUCH AS A LIPOSOME COMPRISING 1,2-DISTEAROYL-SN-PHOSPHATIDYLCHOLINE, CHOLESTEROL AND N-(OMEGA-METHOXY-POLY(ETHYLENE GLYCOL)...; REG. NO/DATE: EU/1 /16/1130 20161018 |
1412357 | PA2008013 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: SITAGLIPTINUM PHOSPHAS MONOHYDRICUS, METFORMINI HYDROCHLORIDUM; REG. NO/DATE: EU/1/08/455/001-014 20080716 |
0434450 | C990028 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: ABACAVIR, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT EN/OF VAN EEN FARMACEUTISCH AANVAARDBAAR ESTER, IN HET BIJZONDER ABACAVIR SULFAAT; REGISTRATION NO/DATE: EU/1/99/112/001-002 19990708 |
2957286 | SPC/GB19/003 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: PATIROMER SORBITEX CALCIUM; REGISTERED: UK EU/1/17/1179/001(NI) 20170721; UK EU/1/17/1179/002(NI) 20170721; UK EU/1/17/1179/003(NI) 20170721; UK EU/1/17/1179/004(NI) 20170721; UK EU/1/17/1179/005(NI) 20170721; UK EU/1/17/1179/006(NI) 20170721; UK EU/1/17/1179/007(NI) 20170721; UK EU/1/17/1179/008(NI) 20170721; UK EU/1/17/1179/009(NI) 20170721; UK PLGB 50784/0002-0001 20170721; UK PLGB 50784/0003-0001 20170721; UK PLGB 50784/0004-0001 20170721 |
0347066 | 42/2002 | Austria | ⤷ Try a Trial | PRODUCT NAME: ESCITALOPRAM UND DESSEN NICHT-TOXISCHE SAEUREADDITIONSSALZE; NAT. REGISTRATION NO/DATE: 1-24549, 1-24550, 1-24551, 1-24552 20020618; FIRST REGISTRATION: SE 17084, 17085, 17086,17087 20011207 |
0277829 | C300016 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: GANIRELIX, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; NATL REGISTRATION NO/DATE: EU/1/00/130/001-002 20000517 |
0542411 | C300397 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: PRASUGREL, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; REGISTRATION NO/DATE: EU/1/08/503/001-014 20090225 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.